U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ELOCTATE
  1. Approved Blood Products

STN: BL 125487
Proper Name: Antihemophilic Factor (Recombinant), FcFusion Protein
Tradename: ELOCTATE
Manufacturer: Biogen Idec, Inc.

Indication: 

  • For adults and children with Hemophilia A for (1)  on-demand treatment and control of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Product Information

Supporting Documents

Back to Top